Sigma-Aldrich posts 15% rise in Q4 net profit
Revenue increased 5% to $610m including 2% points from acquisitions, the company repoted. The company’s research-chemicals segment, its biggest contributor to the top line, reported sales were up
Isomorphic Labs has raised $5bn in a Series C financing round to support the development of its AI platform and advance its therapeutic candidates towards clinical evaluation.
According to the collaboration, Genmab creates novel human antibodies to three targets identified by Lundbeck. Lundbeck has access to Genmab’s antibody creation and development capabilities, including its fully
Catalyst’s intellectual property is a method of treating Tourette Syndrome using GABA aminotransferase inhibitor drugs, including CPP-109 and CPP-115. The method increases presynaptically stored GABA, and enhance GABA